Clinical Trial: Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.)
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title:
Brief Summary: As studies demonstrate, the administration of recombinant human GH (rhGH) in adults with GH deficiency has been known to improve metabolic impairment and quality of life. Patients, however, do have to tolerate daily injections of GH (rhGH).
Detailed Summary:
Sponsor: LG Life Sciences
Current Primary Outcome: Safety [ Time Frame: 12 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Efficacy [ Time Frame: 12 weeks ]
Original Secondary Outcome: Same as current
Information By: LG Life Sciences
Dates:
Date Received: May 22, 2012
Date Started: December 2009
Date Completion:
Last Updated: October 3, 2012
Last Verified: October 2012